Literature DB >> 19484153

In search of a better platelet ADP-receptor blocker.

F W A Verheugt1.   

Abstract

Entities:  

Year:  2009        PMID： 19484153      PMCID： PMC2688015          DOI： 10.1007/BF03086244

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


× No keyword cloud information.
  9 in total

1.  Cangrelor increases the magnitude of platelet inhibition and reduces interindividual variability in clopidogrel-pretreated subjects.

Authors:  H J Bouman; J W van Werkum; C M Hackeng; N Clappers; J M Ten Berg
Journal:  Neth Heart J       Date:  2009-05       Impact factor: 2.380

2.  Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.

Authors:  Z M Chen; L X Jiang; Y P Chen; J X Xie; H C Pan; R Peto; R Collins; L S Liu
Journal:  Lancet       Date:  2005-11-05       Impact factor: 79.321

3.  Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.

Authors:  S R Mehta; S Yusuf; R J Peters; M E Bertrand; B S Lewis; M K Natarajan; K Malmberg; H Rupprecht; F Zhao; S Chrolavicius; I Copland; K A Fox
Journal:  Lancet       Date:  2001-08-18       Impact factor: 79.321

4.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

Authors:  S Yusuf; F Zhao; S R Mehta; S Chrolavicius; G Tognoni; K K Fox
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

5.  Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.

Authors:  Marc S Sabatine; Christopher P Cannon; C Michael Gibson; Jose L López-Sendón; Gilles Montalescot; Pierre Theroux; Marc J Claeys; Frank Cools; Karen A Hill; Allan M Skene; Carolyn H McCabe; Eugene Braunwald
Journal:  N Engl J Med       Date:  2005-03-09       Impact factor: 91.245

6.  Prasugrel versus clopidogrel in patients with acute coronary syndromes.

Authors:  Stephen D Wiviott; Eugene Braunwald; Carolyn H McCabe; Gilles Montalescot; Witold Ruzyllo; Shmuel Gottlieb; Franz-Joseph Neumann; Diego Ardissino; Stefano De Servi; Sabina A Murphy; Jeffrey Riesmeyer; Govinda Weerakkody; C Michael Gibson; Elliott M Antman
Journal:  N Engl J Med       Date:  2007-11-04       Impact factor: 91.245

7.  Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial.

Authors:  Christopher P Cannon; Steen Husted; Robert A Harrington; Benjamin M Scirica; Håkan Emanuelsson; Gary Peters; Robert F Storey
Journal:  J Am Coll Cardiol       Date:  2007-10-23       Impact factor: 24.094

8.  Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study.

Authors:  M E Bertrand; V Legrand; J Boland; E Fleck; J Bonnier; H Emmanuelson; M Vrolix; L Missault; S Chierchia; M Casaccia; L Niccoli; A Oto; C White; M Webb-Peploe; E Van Belle; E P McFadden
Journal:  Circulation       Date:  1998-10-20       Impact factor: 29.690

9.  Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial.

Authors:  Stephen D Wiviott; Dietmar Trenk; Andrew L Frelinger; Michelle O'Donoghue; Franz-Josef Neumann; Alan D Michelson; Dominick J Angiolillo; Hanoch Hod; Gilles Montalescot; Debra L Miller; Joseph A Jakubowski; Richard Cairns; Sabina A Murphy; Carolyn H McCabe; Elliott M Antman; Eugene Braunwald
Journal:  Circulation       Date:  2007-12-03       Impact factor: 29.690
  9 in total
  1 in total

Review 1.  Shear-Dependent Platelet Aggregation: Mechanisms and Therapeutic Opportunities.

Authors:  Akshita Rana; Erik Westein; Be'eri Niego; Christoph E Hagemeyer
Journal:  Front Cardiovasc Med       Date:  2019-09-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.